These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 17090399)

  • 21. Role of Isradipine Loaded Solid Lipid Nanoparticles on the Pharmacodynamic Effect in Rats.
    Thirupathi G; Swetha E; Narendar D
    Drug Res (Stuttg); 2017 Mar; 67(3):163-169. PubMed ID: 27992936
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Enhancement of gastrointestinal absorption of quercetin by solid lipid nanoparticles.
    Li H; Zhao X; Ma Y; Zhai G; Li L; Lou H
    J Control Release; 2009 Feb; 133(3):238-44. PubMed ID: 18951932
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nitrendipine nanocrystals: its preparation, characterization, and in vitro-in vivo evaluation.
    Quan P; Xia D; Piao H; Piao H; Shi K; Jia Y; Cui F
    AAPS PharmSciTech; 2011 Dec; 12(4):1136-43. PubMed ID: 21892695
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preparation, characterization and in vivo distribution of solid lipid nanoparticles loaded with syringopicroside.
    Zhang X; Lü S; Han J; Sun S; Wang L; Li Y
    Pharmazie; 2011 Jun; 66(6):404-7. PubMed ID: 21699077
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Sildenafil citrate as oral solid lipid nanoparticles: a novel formula with higher bioavailability and sustained action for treatment of erectile dysfunction.
    Hosny KM; Aljaeid BM
    Expert Opin Drug Deliv; 2014 Jul; 11(7):1015-22. PubMed ID: 24746063
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preparation, characterization, and in vitro and in vivo evaluation of lovastatin solid lipid nanoparticles.
    Suresh G; Manjunath K; Venkateswarlu V; Satyanarayana V
    AAPS PharmSciTech; 2007 Mar; 8(1):24. PubMed ID: 17408223
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Solid Lipid Nanoparticles of Dronedarone Hydrochloride for Oral Delivery: Optimization, In Vivo Pharmacokinetics and Uptake Studies.
    Gambhire VM; Gambhire MS; Ranpise NS
    Pharm Nanotechnol; 2019; 7(5):375-388. PubMed ID: 31376827
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative study of nisoldipine-loaded nanostructured lipid carriers and solid lipid nanoparticles for oral delivery: preparation, characterization, permeation and pharmacokinetic evaluation.
    Dudhipala N; Janga KY; Gorre T
    Artif Cells Nanomed Biotechnol; 2018; 46(sup2):616-625. PubMed ID: 29688077
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development, characterization and nasal delivery of rosmarinic acid-loaded solid lipid nanoparticles for the effective management of Huntington's disease.
    Bhatt R; Singh D; Prakash A; Mishra N
    Drug Deliv; 2015; 22(7):931-9. PubMed ID: 24512295
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preparation, characterization and in vitro release kinetics of clozapine solid lipid nanoparticles.
    Venkateswarlu V; Manjunath K
    J Control Release; 2004 Mar; 95(3):627-38. PubMed ID: 15023472
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tissue distribution of borneol-modified ganciclovir-loaded solid lipid nanoparticles in mice after intravenous administration.
    Ren J; Zou M; Gao P; Wang Y; Cheng G
    Eur J Pharm Biopharm; 2013 Feb; 83(2):141-8. PubMed ID: 23201052
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Injectable actarit-loaded solid lipid nanoparticles as passive targeting therapeutic agents for rheumatoid arthritis.
    Ye J; Wang Q; Zhou X; Zhang N
    Int J Pharm; 2008 Mar; 352(1-2):273-9. PubMed ID: 18054182
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Solid lipid nanoparticles (SLNs) to improve oral bioavailability of poorly soluble drugs.
    Hu L; Tang X; Cui F
    J Pharm Pharmacol; 2004 Dec; 56(12):1527-35. PubMed ID: 15563759
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Formulation, Characterization, and Evaluation of Eudragit-Coated Saxagliptin Nanoparticles Using 3 Factorial Design Modules.
    Alhamhoom Y; Ravi G; Osmani RAM; Hani U; Prakash GM
    Molecules; 2022 Nov; 27(21):. PubMed ID: 36364338
    [No Abstract]   [Full Text] [Related]  

  • 35. Gastrointestinal stability, physicochemical characterization and oral bioavailability of chitosan or its derivative-modified solid lipid nanoparticles loading docetaxel.
    Shi LL; Lu J; Cao Y; Liu JY; Zhang XX; Zhang H; Cui JH; Cao QR
    Drug Dev Ind Pharm; 2017 May; 43(5):839-846. PubMed ID: 27487431
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Formulation development of linagliptin solid lipid nanoparticles for oral bioavailability enhancement: role of P-gp inhibition.
    Shah P; Chavda K; Vyas B; Patel S
    Drug Deliv Transl Res; 2021 Jun; 11(3):1166-1185. PubMed ID: 32804301
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enhanced Oral Bioavailability of Felodipine from Solid Lipid Nanoparticles Prepared Through Effervescent Dispersion Technique.
    He Y; Zhan C; Pi C; Zuo Y; Yang S; Hu M; Bai Y; Zhao L; Wei Y
    AAPS PharmSciTech; 2020 Jun; 21(5):170. PubMed ID: 32529303
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Galactosylated solid lipid nanoparticles with cucurbitacin B improves the liver targetability.
    Wang W; Zhao X; Hu H; Chen D; Gu J; Deng Y; Sun J
    Drug Deliv; 2010 Apr; 17(3):114-22. PubMed ID: 20148709
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization and stability of nanostructured lipid carriers as drug delivery system.
    Abbasalipourkabir R; Salehzadeh A; Abdullah R
    Pak J Biol Sci; 2012 Feb; 15(3):141-6. PubMed ID: 22866544
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Investigations of the effect of the lipid matrix on drug entrapment, in vitro release, and physical stability of olanzapine-loaded solid lipid nanoparticles.
    Vivek K; Reddy H; Murthy RS
    AAPS PharmSciTech; 2007 Oct; 8(4):E83. PubMed ID: 18181544
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.